Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Mazor Advances Most Since October on FDA Approval of System

Don't Miss Out —
Follow us on:

Dec. 5 (Bloomberg) -- Mazor Robotics Ltd. rose the most in almost two months after receiving approval from the U.S. Food and Drug Administration for the three dimensional use of its Renaissance system.

Shares in the developer of surgical robots surged 9.3 percent, the most since Oct. 16, to 4.246 shekels at the 4:30 p.m. close in Tel Aviv.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.